Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance

Research output: Contribution to journal › Article › Academic › peer-review

14 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	673-689
Journal	Expert Opinion on Drug Metabolism and Toxicology
Volume	11
Issue number	5
DOIs	https://doi.org/10.1517/17425255.2015.993316
Publication status	Published - 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f1e3e05a7b364f74948f58e95de1c1db,

title = "Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance",

author = "A.M. Wojtuszkiewicz and Y.G. Assaraf and M.J.P. Maas and G.J.L. Kaspers and G. Jansen and J. Cloos",

year = "2015",

doi = "10.1517/17425255.2015.993316",

language = "Undefined/Unknown",

volume = "11",

pages = "673--689",

journal = "Expert Opinion on Drug Metabolism and Toxicology",

issn = "1742-5255",

publisher = "Taylor and Francis Ltd.",

number = "5",

}

TY - JOUR

T1 - Pre-mRNA splicing in cancer: the relevance in oncogenesis, treatment and drug resistance

AU - Wojtuszkiewicz, A.M.

AU - Assaraf, Y.G.

AU - Maas, M.J.P.

AU - Kaspers, G.J.L.

AU - Jansen, G.

AU - Cloos, J.

PY - 2015

Y1 - 2015

U2 - 10.1517/17425255.2015.993316

DO - 10.1517/17425255.2015.993316

M3 - Article

C2 - 25495223

SN - 1742-5255

VL - 11

SP - 673

EP - 689

JO - Expert Opinion on Drug Metabolism and Toxicology

JF - Expert Opinion on Drug Metabolism and Toxicology

IS - 5

ER -